FHIL - ETF AI Analysis
Top Page
Federated Hermes International Leaders ETF (FHIL)
Rating:62Neutral
Price Target:―
Positive Factors
Strong Semiconductor Leaders
Key holdings in major chipmakers have shown strong recent performance, helping support the ETF’s returns.
Broad International Diversification
The fund spreads its investments across several countries in Europe, Asia, and the U.S., reducing reliance on any single market.
Balanced Sector Mix
Exposure to financials, technology, health care, industrials, and other sectors helps smooth out the impact of weakness in any one industry.
Negative Factors
Recent Negative Year-to-Date Performance
The ETF’s overall performance so far this year has been weak, which may concern investors looking for near-term gains.
Several Top Holdings Are Lagging
Some of the largest positions, including major health care and industrial names, have shown weak recent performance that can drag on the fund.
Moderate Expense Ratio
The fund’s fees are not especially low, which means costs could eat into returns compared with cheaper international ETFs.
FHIL vs. SPDR S&P 500 ETF (SPY)
AUM2.49M
RegionDeveloped Markets
Expense Ratio0.48%
Beta0.67
IssuerFederated Hermes
Inception DateJun 17, 2026
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume762
30 Day Avg. Volume1,972
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
30.26Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering75
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FHIL Summary
Federated Hermes International Leaders ETF (FHIL) is an actively managed fund that looks for solid companies outside the U.S., with the flexibility to also own some U.S. and emerging-market stocks. It focuses on businesses the managers believe are trading for less than they’re worth, across many countries and sectors. Well-known holdings include AstraZeneca and ASML. Someone might invest in FHIL to add international diversification and potential long-term growth to a U.S.-heavy portfolio. A key risk is that global stock prices, and currency values, can move up and down, which may cause the ETF’s value to fluctuate significantly.
How much will it cost me?This ETF has an expense ratio of 0.48%, which means you’ll pay about $4.80 per year for every $1,000 you invest. That’s higher than the average low-cost index ETF because this fund is actively managed, with managers researching and selecting stocks rather than just tracking an index.
What would affect this ETF?This ETF could benefit if international economies outside the U.S. strengthen, especially in sectors like financials, technology, and health care, and if value-style stocks come back into favor, helping holdings such as AstraZeneca, ASML, TSMC, and HSBC. On the other hand, global slowdowns, rising interest rates that hurt banks and other financials, regulatory changes affecting big tech and health care companies, or country-specific issues in developed markets could weigh on performance.
FHIL Top 10 Holdings
FHIL’s story is being written largely by its international tech and financial heavyweights. Chip leaders TSMC and ASML have been rising, giving the fund a solid tailwind from the global semiconductor boom. Nokia has also perked up recently, adding some extra spark on the communications side. On the flip side, AstraZeneca has been lagging, and luxury giant LVMH has been losing some shine, both acting as mild brakes. With holdings spread across Europe and Asia and little U.S. exposure, this is very much a developed-markets ex-U.S. value play.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| TSMC | 2.79% | $69.48K | $1.97T | 76.21% | 81 Outperform | |
| ASML Holding NV | 2.53% | $63.06K | €560.52B | 115.72% | 76 Outperform | |
| ― | 2.51% | $62.43K | ― | ― | ― | |
| AstraZeneca | 2.40% | $59.89K | $253.04B | -0.69% | 80 Outperform | |
| Sony Group | 2.38% | $59.31K | $147.33B | -10.92% | 75 Outperform | |
| ― | 2.30% | $57.22K | ― | ― | ― | |
| Sumitomo Mitsui | 2.27% | $56.46K | $171.82B | 66.06% | 76 Outperform | |
| Deutsche Bank AG | 2.24% | $55.90K | $77.43B | 17.41% | 69 Neutral | |
| UniCredit SpA | 2.14% | $53.35K | €126.17B | 25.50% | 75 Outperform | |
| Mitsubishi UFJ | 2.14% | $53.24K | $270.87B | 57.76% | 77 Outperform |
FHIL Technical Analysis
Positive
―
Price Trends
24.93
Positive
Market Momentum
-0.04
Positive
49.01
Neutral
38.16
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FHIL, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 25.16, equal to the 50-day MA of 24.93, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -0.04 indicates Positive momentum. The RSI at 49.01 is Neutral, neither overbought nor oversold. The STOCH value of 38.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FHIL.
FHIL Peer Comparison
Comparison Results
Performance Comparison
FHIL
Federated Hermes International Leaders ETF
25.00
-0.21
-0.83%
DFIV
Dimensional International Value ETF
―
―
―
TISC
Thrivent International Small Cap ETF
―
―
―
RWIN
Rayliant NxtGen Multifactor International Equity ETF
―
―
―
FFDI
Fidelity Fundamental Developed International ETF
―
―
―
TXUG
Thornburg International Growth Fund ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents